<DOC>
	<DOCNO>NCT00002620</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell may effective treatment patient anaplastic astrocytomas . PURPOSE : Randomized phase III trial study effectiveness radiation therapy treat patient anaplastic astrocytomas .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Brain Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare disease-free interval survival patient supratentorial malignant brain glioma randomize radiotherapy alone vs. radiotherapy plus radiosensitization mitolactol ( DBD ) follow DBD carmustine . OUTLINE : Randomized study . Group I : Radiotherapy . External-beam cranial irradiation megavoltage equipment . Group II : Radiotherapy Radiosensitization follow Maintenance Chemotherapy . Radiotherapy Group I ; Mitolactol , DBD , NSC-104800 ; follow DBD ; Carmustine , BCNU , NSC-409962 . PROJECTED ACCRUAL : A total 212 patient enter 3 year .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>Mitolactol</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm anaplastic astrocytoma Standard maximum resection stereotactic biopsy require within 4 week prior therapy PATIENT CHARACTERISTICS : Age : Over 16 Performance status : ECOG/ZUBROD/WHO 02 Life expectancy : At least 8 week Hematopoietic : WBC great 4,000 Platelets great 100,000 Hematocrit great 30 % Hepatic : Bilirubin le 2 mg/dl Renal : Creatinine le 1.5 mg/dl Creatinine clearance great 70 ml/min BUN le 40 mg/dl Other : No major medical illness PRIOR CONCURRENT THERAPY : No anticancer drug surgery protocol treatment No steroids 10 day follow surgery ( may resume occasionally radiotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>adult anaplastic astrocytoma</keyword>
</DOC>